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Background:  Calcium density was recently found to be inversely associated with incident coronary heart disease (CHD) and 
cardiovascular disease (CVD) events. Not known is whether this relationship may differ in those with diabetes (DM) or metabolic syndrome 
(MetS).
methods:  The Multiethnic Study of Atherosclerosis is a cohort study of 6,814 participants aged 45-84 years. We included 3,826 
participants with a non-zero Agatston score and classified them as having DM (18%), MetS without DM (29%) or neither condition (53%). 
The relation of coronary artery calcium (CAC) density and volume scores with incident CHD and CVD events was examined stratified by 
statin use.
results:  During a 9.3 year mean follow-up, 67 (10%), 79 (7%), 102 (5%) CHD events happened in those with DM, MetS, or neither 
condition, respectively. CAC density score (adjusted for volume score) was inversely associated with CHD/CVD; in those with MetS or DM, 
this relation appeared strongest in non-statin users (Table). Volume score (adjusted for density) was positively associated with CHD and 
CVD events. The 4th quartile of density score in those with MetS had a 73% lower risk (p<0.01) than those in 1st quartile for CHD events 
compared to 24% (p=0.56) and 36% (p=0.37) for those with neither condition or DM, respectively.
conclusion:  Density score is inversely related to CHD and CVD, but in those with MetS or DM this appears strongest in those not on 
statins, suggesting statin use may attenuate the association between CAC density and incident CHD events.
Adjusted standardized hazard ratio (95% confidence interval) for CAC volume and density scores for Hard CHD and Hard CVD among 
those with statin use vs. without statin use in three disease groups.
Diabetes (n=671) MetS (n=1124) Neither Disease (n=2031)
Statin (n=219) Non-Statin (n=452) Statin (n=254) Non-Statin (n=868) Statin (n=377) Non-Statin (n=1654)
CHD
ln(volume),
per SD
1.59
(1.09-2.33)*
2.08
(1.05-4.11)*
1.50
(0.75-3.00)
2.01
(1.38-2.94)***
2.25
(1.13-4.47)*
2.11
(1.57-2.85)****
CAC density,
per SD
1.10
(0.71-1.70)
0.52
(0.24-1.11)
0.77
(0.36-1.65)
0.51
(0.34-0.78) **
0.47
(0.21-1.03)
0.80
(0.57-1.12)
CVD
ln(volume),
per SD
1.56
(1.13-2.16)**
2.03
(1.19-3.45)**
1.67
(0.91-3.09) 1.50(1.13-1.99)**
1.71
(0.97-3.01)
1.89
(1.48-2.42)****
CAC density,
per SD
0.99
(0.69-1.41)
0.58
(0.32-1.06)
0.83
(0.41-1.67)
0.74
(0.55-1.01)
0.62
(0.33-1.17)
0.73
(0.56-0.96)*
Adjusted for 10-yr ASCVD risk, ethnicity and BMI. 1 SD of ln(volume) = 6.07;1 SD of density score = 0.76.
* p<0.05, ** p<0.01, *** p<0.001, ****p<0.0001.
